|The LAMP1 lamp1 (Catalog #MBS8221137) is a Blocking Peptide produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The CD107a Blocking Peptide reacts with Human, Mouse, Rat, Monkey and may cross-react with other species as described in the data sheet. MyBioSource\'s CD107a can be used in a range of immunoassay formats including, but not limited to, Blocking (BL). Researchers should empirically determine the suitability of the LAMP1 lamp1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The LAMP1 lamp1 product has the following accession number(s) (GI #112380628) (NCBI Accession #NP_005552.3) (Uniprot Accession #P11279). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The peptide is used to block Anti-CD107a Antibody reactivity.
Quality Control: The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Directions for Use: Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours. Blood, Bone, Bone Marrow, Brain, Kidney, Liver, Lung, Muscle, Nerve, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene. LAMP1 also interacts with the following gene(s): CD63, EEA1, EGFR, IL21, NCAM1, RAB5A, RAB7A. Brain Diseases, Disease Models, Animal, Fibrosis, Inflammation, Liver Diseases, Lung Diseases, Lung Neoplasms, Necrosis, Neoplasms, Experimental, Nervous System Diseases are some of the diseases may be linked to CD107a Blocking Peptide.